Function in Subacute Organophosphate Poisoning Induced by Phosmet

Total Page:16

File Type:pdf, Size:1020Kb

Function in Subacute Organophosphate Poisoning Induced by Phosmet 2902Journal ofNeurology, Neurosurgery, and Psychiatry 1993;56:290-294 SHORT REPORT J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.56.3.290 on 1 March 1993. Downloaded from Pathophysiological studies of neuromuscular function in subacute organophosphate poisoning induced by phosmet J L Good, R K Khurana, R F Mayer, W M Cintra, E X Albuquerque Abstract suggested a neuromuscular junction (NMJ) A 51 year old man developed progressive defect of the postsynaptic type, but the exact cranial and proximal muscle weakness, mechanism of the dysfunction was not deter- hyperreflexia and mental change. The mined. 5o disorder progressed over 9 days following We describe the pathophysiological changes the fifth weekly spraying with the organo- in a patient who presented with a subacute phosphate (OP) insecticide, phosmet, progressive neuromuscular syndrome without with limited symptoms of acute toxicity. marked symptoms of acute toxicity after multi- Marked decremental responses of 50-80% ple OP insecticide sprayings. The defect in this on slow and fast rates of stimulation were neuromuscular syndrome occurred at the improved to 15% by edrophonium or endplate-receptor sites, is similar to the inter- neostigmine. Intracellular recordings at mediate syndrome previously reported,10 and the endplate region of intercostal muscle differs from the acute and delayed syndromes. l revealed small miniature endplate poten- These results are important in the diagnosis tials (mepps), reduced mean acetylcho- and management of patients exposed to line sensitivity and normal membrane organophosphates. A preliminary report of potentials. Electronmicroscopy revealed this study has been published in abstract degeneration and regeneration of the form. " endplates. This study demonstrates that OP poisoning due to phosmet can produce a subacute postsynaptic neuromuscular Case report syndrome without marked symptoms of A 51 year old man was admitted to the hospital acute toxicity. 5 days after the onset of diplopia, light headed- ness and a staggering gait. The patient devel- (7 Neurol Neurosurg Psychiatry 1993;56:290-294) oped these symptoms 18 hours after the fifth weekly exposure to a liquid spray insecticide http://jnnp.bmj.com/ University of Organophosphate (OP) insecticide poisoning containing an organophosphate compound, Maryland School of can acute acid Medicine, Baltimore, in humans produce: 1) peripheral phosmet, (phosphorodiothioic S-[(1,3-di- Maryland, USA and central cholinergic block; 2) an inter- hydro-1 ,3-dioxo-2H-isoindol-2-yl) methyl] 0,0- Department of mediate syndrome with weakness, and 3) a dimethylester). He described his face and Neurology delayed distal polyneuropathy. l The acute syn- hands becoming wet from the insecticide and J L Good R K Khurana drome that occurs 12 to 72 hours after he did not bathe until the following morning. R F Mayer exposure to OP involves inhibition of acetyl- Over the next few days, he noted progressive on September 24, 2021 by guest. Protected copyright. Department of cholinesterase (AChE) by the OP24 and direct unsteadiness of gait, dysphagia, change in Pharmacology and actions at the synapse involving a variety of voice tone and excessive diaphoresis. Five days Experimental Therapeutics chemosensitive receptor ion channels.`- Cen- after exposure, he noted jaw weakness and E X Albuquerque tral and peripheral cholinergic signs occur. The droopy eyelids. Laboratory of neuromuscular block to repetitive nerve stim- The patient's general examination was nor- Molecular ulation shows decremental responses that are mal. Profuse oral secretions, bilateral ptosis, Pharmacology II, increased by edrophonium.8 The delayed neu- and marked facial diaphoresis were noted. He Institute of Biophysics "Carlos Chagas ropathic syndrome occurs 1-3 weeks after was alert, mentation was normal, and speech Filho", Federal exposure to the OP and probably results from was dysarthric. Extraocular movements were University of Rio De inhibition of the neurotoxic esterase.9 A distal limited in all directions with the exception of Janeiro, Rio De Janeiro, Brazil axonopathy usually occurs with sensory and downgaze. Pupils were 3 mm and reactive to W M Cintra motor signs. More recently, an intermediate light. There was moderate symmetrical weak- Correspondence to: syndrome has been described in OP poisoning ness of facial, jaw, tongue and neck muscles. Dr Good, Department of that occurs 1-4 after the acute poison- There was mild weakness distal muscles and Neurology, Room N4W46, days of University of Maryland ing.'0 The patients reported developed pro- marked weakness of proximal muscles, es- Hospital, 22 S Greene weakness that was often severe and muscles that The Street, Baltimore, MD gressive pecially antigravity fatigued. 21201, USA involved cranial, respiratory and proximal limb tendon jerks were brisk throughout. Bilateral Received 17 December 1991 muscles which persisted for up to 18 days. Babinski responses were present. Sensory and in revised form Three of the patients had signs suggesting examination was normal. 11 March 1992. Accepted 16 March 1992 CNS dysfunction. Electromyographic studies The patient was admitted with the presumed Endplate studies in OP poisoning 291 diagnosis of acute OP poisoning. Atropine and care was taken to keep the patient warm J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.56.3.290 on 1 March 1993. Downloaded from (2 mg) and pralidoxime chloride (2-PAM, (rectal temperature of 37°C) during the proce- 1 gm) infusions were started. Within several dure. Recordings were obtained at 9 to 95 days minutes of 2-PAM infusion, the patient had after exposure to phosmet. increased systemic and ventilatory weakness Repetitive stimulation was performed at requiring intubation. After the patient was rates of 2, 5, 10, 20, and 50 Hz for 9 responses stabilised on a ventilator, 3 additional doses of in the median and peroneal nerves. Recordings 2-PAM were given without side effects over the of the median nerve were made before and next 24 hours. Atropine (1 0 mg initially and after 10 mg of intravenous edrophonium at thereafter 0-5 mg) was continued 4 times daily days 11 to 47. Recordings were made 5 to 40 for 6 days. Paralysis was maximum on day 9. minutes after 1-5 mg of intramuscular neo- At this time, he was observed to have visual stigmine on day 12. Measurements of the hallucinations, disorientation, and myoclonic motor amplitudes were peak-to-peak and per- jerks of his extremities. These signs persisted centage change (decrement) was calculated for for approximately 10 days during which time the fourth and ninth responses compared with the EEC showed diffuse slow wave activity. the initial one. The patient remained unchanged for the Concentric needle and single fibre (SF following 18 days, and supportive care con- EMG) electromyography and fibre densities tinued. By day 28, there was improvement in were performed in the extensor digitorum strength of neck flexion, shoulder and anti- communis and first dorsal interosseus muscles gravity muscles. By day 44, he no longer using established techniques. 14 SF EMG required mechanical ventilation or tube feed- recordings were obtained when the patient was ings. Babinski responses were absent. Exam- improving and able to cooperate, 3-4 months ination on day 64 (time of the muscle biopsy) after exposure. showed that he had mild fatiguable proximal A diagnostic intercostal muscle biopsy was and antigravity muscle weakness in the upper obtained 2 months after exposure because of and lower limbs. Facial and oropharyngeal persistent muscle weakness with informed movements were near normal. There was mild consent by the patient. Muscle was removed subjective diplopia on extreme lateral gaze. from the right sixth intercostal space in the Neuromuscular examination was normal by 5 anterior axillary line using standardised aneas- months. thesia and surgical technique. The muscle was Laboratory studies revealed normal routine immediately placed in oxygenated Krebs- blood and urine studies, creatine kinase, EKG Ringer solution and prepared for intracellular and chest radiographs. MRI of the brain was recordings and ultrastructure as previously normal. CSF was normal except for a total described.'5 Conventional microelectrode protein of 75 mg%. On admission red blood techniques were used for recording from cell cholinesterase level was within normal human intercostal muscle. High resistance limits (6110 U/L); and follow up levels on days pipettes (approximately 150 MQ) filled with 16 and 23 were 5420 and 4180 respectively 2 5 M acetylcholine (ACh) were used for and at 10 months (5114 U/L) remained nor- microiontophoretic application of ACh at the mal (normal range 6666-3590). Studies to neuromuscular junctions. Results were com- rule out other causes of neuromuscular disease pared statistically (Student t test) with control were normal. ANA and acetylcholine receptor data that we have obtained from normal adult http://jnnp.bmj.com/ antibody titres were negative. human intercostal muscle biopsied during thoracotomies for cardiopulmonary disease. The muscle fibres were fixed in ice-cold Methods phosphate buffered 2-5% glutaraldehyde for Nerve conduction and repetitive stimulation- thin sectioning and electron microscopic neuromuscular studies were performed in examination of the endplate regions.'5 16 peripheral nerves of upper and lower extrem- on September 24, 2021 by guest. Protected copyright. ities using established techniques.'2 53 Record- ings were performed in the intensive care unit Results Clinical electrophysiology Table 1 Nerve conduction and repetitive stimulation studies in median nerve after Initial recordings were performed 9 days after phosmet exposure exposure at which time the weakness was maximal. Electromyography at this time did % Decrement at 5 Hz not show any spontaneous activity such as Before After Tensilon fasciculations or fibrillation potentials. In Time CMAP DL MCV Days mV MS MIS 4th R 9th R 4th R 9th R median, ulnar and peroneal nerves, distal motor responses were mildly reduced in ampli- 9 90 50 54 48 43 1 1 11-6 55 43 33 19 tude and prolonged in latency. Motor conduc- 12 13-0 58 46 10 7 tion velocities were normal.
Recommended publications
  • Severe Organophosphate Poisoning with Delayed Cholinergic Crisis, Intermediate Syndrome and Organophosphate Induced Delayed Polyneuropathy on Succession
    Organophosphate Poisoning… Aklilu A 203 CASE REPORT SEVERE ORGANOPHOSPHATE POISONING WITH DELAYED CHOLINERGIC CRISIS, INTERMEDIATE SYNDROME AND ORGANOPHOSPHATE INDUCED DELAYED POLYNEUROPATHY ON SUCCESSION Aklilu Azazh ABSTRACT Organophosphate compounds are the organic derivatives of Phosphorous containing acids and their effect on neuromuscular junction and Autonomic Synapses is clinically important. After exposure these agents cause acute and sub acute manifestations depending on the type and severity of the agents like Acute Cholinergic Manifestations, Intermediate Syndrome with Nicotinic features and Delayed Central Nervous System Complications. The patient reported here had severe Organophosphate Poisoning with various rare complications on a succession. This is the first report of Organophosphates Poisoning complicated by Intermediate Syndrome and Organophosphate Induced Delayed Polyneuropathy in Ethiopia and it is reported to increase awareness of health care workers on these rare complications of a common problem. INTRODUCTION phosphorylated by the Phosphate end of Organophosphates; then the net result is Organophosphate compounds are the organic accumulation of excessive Acetyl Chlorine with derivatives of Phosphorous containing acids and resultant effect on Muscarinic, Nicotinic and their effect on Neuromuscular Junction and central nervous system (Figure 2). Autonomic synapses is clinically important. In the Neuromuscular Junction Acetylcholine is released Following classical OP poisoning, three well when a nerve impulse reaches
    [Show full text]
  • Protocol for a Randomised Controlled Trial: Efficacy of Donepezil Against
    BMJ Open: first published as 10.1136/bmjopen-2013-003533 on 25 September 2013. Downloaded from Open Access Protocol Protocol for a randomised controlled trial: efficacy of donepezil against psychosis in Parkinson’s disease (EDAP) Hideyuki Sawada, Tomoko Oeda To cite: Sawada H, Oeda T. ABSTRACT ARTICLE SUMMARY Protocol for a randomised Introduction: Psychosis, including hallucinations and controlled trial: efficacy of delusions, is one of the important non-motor problems donepezil against psychosis Strengths and limitations of this study in patients with Parkinson’s disease (PD) and is in Parkinson’s disease ▪ In previous randomised controlled trials for (EDAP). BMJ Open 2013;3: possibly associated with cholinergic neuronal psychosis the efficacy was investigated in patients e003533. doi:10.1136/ degeneration. The EDAP (Efficacy of Donepezil against who presented with psychosis and the primary bmjopen-2013-003533 Psychosis in PD) study will evaluate the efficacy of endpoint was improvement of psychotic symp- donepezil, a brain acetylcholine esterase inhibitor, for toms. By comparison, this study is designed to prevention of psychosis in PD. ▸ Prepublication history for evaluate the prophylactic effect in patients this paper is available online. Methods and analysis: Psychosis is assessed every without current psychosis. Because psychosis To view these files please 4 weeks using the Parkinson Psychosis Questionnaire may be overlooked and underestimated it is visit the journal online (PPQ) and patients with PD whose PPQ-B score assessed using a questionnaire, Parkinson (http://dx.doi.org/10.1136/ (hallucinations) and PPQ-C score (delusions) have Psychosis Questionnaire (PPQ) every 4 weeks. bmjopen-2013-003533). been zero for 8 weeks before enrolment are ▪ The strength of this study is its prospective randomised to two arms: patients receiving donepezil design using the preset definition of psychosis Received 3 July 2013 hydrochloride or patients receiving placebo.
    [Show full text]
  • Neurology of Acute Organophosphate Poisoning
    Indian Perspective Neurology of acute organophosphate poisoning Gagandeep Singh, Dheeraj Khurana1 Departments of Neurology, Dayanand Medical College, Ludhiana, and 1Postgraduate Institute of Medical Education and Research, Chandigarh, India Abstract Acute organophosphate (OP) poisoning is one of the most common poisonings in emergency medicine and toxicological practice in some of the less-developed nations in South Asia. Traditionally, OP poisoning comes under the domain of emergency physicians, internists, intensivists, and toxicologists. However, some of the complications following OP poisoning are neurological and involve neurologists. The pathophysiological basis for the clinical manifestations of OP poisoning is inactivation of the enzyme, acetylcholinesterase at the peripheral nicotinic and muscarinic and central nervous system (CNS) nerve terminals and junctions. Nicotinic manifestations occur in severe cases and late in the course; these comprise of fasciculations and neuromuscular paralysis. There is a good correlation between the electrophysiological abnormalities and the severity of the clinical manifestations. Neurophysiological abnormalities characteristic of nicotinic junctions (mainly neuromuscular junction) dysfunction include: (1) single, supramaximal electrical-stimulus-induced repetitive response/s, (2) decrement–increment response to high frequency (30 Hz) repetitive nerve stimulation (RNS), and (3) decremental response to high frequency (30 Hz) RNS. Atropine ameliorates muscarinic manifestations. Therapeutic Address for correspondence: Dr. Gagandeep Singh, agents that can ameliorate nicotinic manifestations, mainly neuromuscular, are oximes. Department of Neurology, However, the evidence for this effect is inconclusive. This may be due to the fact that Dayanand Medical College, there are several factors that determine the therapeutic effect of oximes. These factors Ludhiana - 141 001, include: The OP compound responsible for poisoning, duration of poisoning, severity of Punjab, India.
    [Show full text]
  • Nicotine and Neurotransmitters
    Module 2 —Legal Doesn’t Mean Harmless Overview Overview Summary This module focuses on how two drugs, nicotine and alcohol, change the functioning of the brain and body. Both drugs are widely used in the community, and for adults, using them is legal. Nonetheless, both alcohol and nicotine can have a strong impact on the functioning of the brain. Each can cause a number of negative effects on the body and brain, ranging from mild symptoms to addiction. The goal of this module is to help students understand that, although nicotine and alcohol are legal for adults, they are not harmless substances. Students will learn about how nicotine and alcohol change or disrupt the process of neurotransmission. Students will explore information on the short- and long- term effects of these two drugs, and also learn why these drugs are illegal for children and teens. Through the media, students are exposed to a great deal of information about alcohol and tobacco, much of which is misleading or scientifically inaccurate. This module will provide information on what researchers have learned about how nicotine and alcohol change the brain, and the resulting implications for safety and health. Learning Objectives At the end of this module: • Students can explain how nicotine disrupts neurotransmission. • Students can explain how alcohol use may harm the brain and the body. • Students understand how alcohol can intensify the effect of other drugs. • Students can define addiction and understand its basis in the brain. • Students draw conclusions about why our society regulates the use of nicotine and alcohol for young people.
    [Show full text]
  • Nerve Agent - Lntellipedia Page 1 Of9 Doc ID : 6637155 (U) Nerve Agent
    This document is made available through the declassification efforts and research of John Greenewald, Jr., creator of: The Black Vault The Black Vault is the largest online Freedom of Information Act (FOIA) document clearinghouse in the world. The research efforts here are responsible for the declassification of MILLIONS of pages released by the U.S. Government & Military. Discover the Truth at: http://www.theblackvault.com Nerve Agent - lntellipedia Page 1 of9 Doc ID : 6637155 (U) Nerve Agent UNCLASSIFIED From lntellipedia Nerve Agents (also known as nerve gases, though these chemicals are liquid at room temperature) are a class of phosphorus-containing organic chemicals (organophosphates) that disrupt the mechanism by which nerves transfer messages to organs. The disruption is caused by blocking acetylcholinesterase, an enzyme that normally relaxes the activity of acetylcholine, a neurotransmitter. ...--------- --- -·---- - --- -·-- --- --- Contents • 1 Overview • 2 Biological Effects • 2.1 Mechanism of Action • 2.2 Antidotes • 3 Classes • 3.1 G-Series • 3.2 V-Series • 3.3 Novichok Agents • 3.4 Insecticides • 4 History • 4.1 The Discovery ofNerve Agents • 4.2 The Nazi Mass Production ofTabun • 4.3 Nerve Agents in Nazi Germany • 4.4 The Secret Gets Out • 4.5 Since World War II • 4.6 Ocean Disposal of Chemical Weapons • 5 Popular Culture • 6 References and External Links --------------- ----·-- - Overview As chemical weapons, they are classified as weapons of mass destruction by the United Nations according to UN Resolution 687, and their production and stockpiling was outlawed by the Chemical Weapons Convention of 1993; the Chemical Weapons Convention officially took effect on April 291997. Poisoning by a nerve agent leads to contraction of pupils, profuse salivation, convulsions, involuntary urination and defecation, and eventual death by asphyxiation as control is lost over respiratory muscles.
    [Show full text]
  • Neurochemical Mechanisms Underlying Alcohol Withdrawal
    Neurochemical Mechanisms Underlying Alcohol Withdrawal John Littleton, MD, Ph.D. More than 50 years ago, C.K. Himmelsbach first suggested that physiological mechanisms responsible for maintaining a stable state of equilibrium (i.e., homeostasis) in the patient’s body and brain are responsible for drug tolerance and the drug withdrawal syndrome. In the latter case, he suggested that the absence of the drug leaves these same homeostatic mechanisms exposed, leading to the withdrawal syndrome. This theory provides the framework for a majority of neurochemical investigations of the adaptations that occur in alcohol dependence and how these adaptations may precipitate withdrawal. This article examines the Himmelsbach theory and its application to alcohol withdrawal; reviews the animal models being used to study withdrawal; and looks at the postulated neuroadaptations in three systems—the gamma-aminobutyric acid (GABA) neurotransmitter system, the glutamate neurotransmitter system, and the calcium channel system that regulates various processes inside neurons. The role of these neuroadaptations in withdrawal and the clinical implications of this research also are considered. KEY WORDS: AOD withdrawal syndrome; neurochemistry; biochemical mechanism; AOD tolerance; brain; homeostasis; biological AOD dependence; biological AOD use; disorder theory; biological adaptation; animal model; GABA receptors; glutamate receptors; calcium channel; proteins; detoxification; brain damage; disease severity; AODD (alcohol and other drug dependence) relapse; literature review uring the past 25 years research- science models used to study with- of the reasons why advances in basic ers have made rapid progress drawal neurochemistry as well as a research have not yet been translated Din understanding the chemi- reluctance on the part of clinicians to into therapeutic gains and suggests cal activities that occur in the nervous consider new treatments.
    [Show full text]
  • Two Types of Muscarinic Response to Acetylcholine in Mammalian Cortical Neurons (Clngulate/M Current/Cholinergic/Pirenzepine) DAVID A
    Proc. Nail. Acad. Sci. USA Vol. 82, pp. 6344-6348, September 1985 Neurobiology Two types of muscarinic response to acetylcholine in mammalian cortical neurons (clngulate/M current/cholinergic/pirenzepine) DAVID A. MCCORMICK AND DAVID A. PRINCE Department of Neurology, Room C338, Stanford University School of Medicine, Stanford, CA 94305 Communicated by Richard F. Thompson, May 22, 1985 ABSTRACT Applications of acetylcholine (AcCho) to py- The cerebral cortex contains nicotinic as well as several ramidal cells of guinea pig cingulate cortical slices maintained subtypes of muscarinic AcCho receptors (20-23). Previous in vitro result in a short latency inhibition, followed by a reports suggest that cholinergic slow excitation is mediated prolonged increase in excitability. Cholinergic inhibition is by receptors possessing muscarinic characteristics, while mediated through the rapid excitation of interneurons that cholinergic inhibition may be due to activation of receptors utilize the inhibitory neurotransmitter y-aminobutyric acid that have both nicotinic and muscarinic properties (5, 24). (GABA). This rapid excitation of interneurons is. associated The recent characterization of receptor antagonists (e.g., with a membrane depolarization and a decrease in neuronal pirenzepine) and agonists (e.g., pilocarpine) that are relative- input resistance. In contrast, AcCho-induced excitation of ly specific for subtypes ofmuscarinic receptors (21, 22) raises pyramidal cells is due to a direct action that produces a the question of whether different types of cholinergic re- voltage-dependent increase in input resistance. In the experi- sponses demonstrated physiologically within the central ments reported here, we investigated the possibility that these nervous system might be due to activation of different two responses are mediated by different subclasses of cholin- subclasses of muscarinic receptors, as appears to be the case ergic receptors.
    [Show full text]
  • Role of Muscarinic Acetylcholine Receptors in Adult Neurogenesis and Cholinergic Seizures
    Role of Muscarinic Acetylcholine Receptors in Adult Neurogenesis and Cholinergic Seizures Rebecca L. Kow A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy University of Washington 2014 Reding Committee: Neil Nathanson, Chair Sandra Bajjalieh Joseph Beavo Program Authorized to Offer Degree: Pharmacology ©Copyright 2014 Rebecca L. Kow University of Washington Abstract Role of Muscarinic Acetylcholine Receptors in Adult Neurogenesis and Cholinergic Seizures Rebecca L. Kow Chair of the Supervisory Committee: Professor Neil M. Nathanson Department of Pharmacology Muscarinic acetylcholine receptors (mAChRs) are G protein-coupled receptors (GPCRs) that mediate important functions in the periphery and in the central nervous systems. In the brain these receptors modulate many processes including learning, locomotion, pain, and reward behaviors. In this work we investigated the role of mAChRs in adult neurogenesis and further clarified the regulation of muscarinic agonist-induced seizures. We first investigated the role of mAChRs in adult neurogenesis in the subventricular zone (SVZ) and the subgranular zone (SGZ). We were unable to detect any modulation of adult neurogenesis by mAChRs. Administration of muscarinic agonists or antagonists did not alter proliferation or viability of adult neural progenitor cells (aNPCs) in vitro. Similarly, muscarinic agonists did not alter proliferation or survival of new adult cells in vivo. Loss of the predominant mAChR subtype in the forebrain, the M1 receptor, also caused no alterations in adult neurogenesis in vitro or in vivo, indicating that the M1 receptor does not mediate the actions of endogenous acetylcholine on adult neurogenesis. We also investigated the interaction between mAChRs and cannabinoid receptor 1 (CB1) in muscarinic agonist pilocarpine-induced seizures.
    [Show full text]
  • Therapeutic Effect of Agmatine on Neurological Disease: Focus on Ion Channels and Receptors
    Neurochemical Research (2019) 44:735–750 https://doi.org/10.1007/s11064-018-02712-1 REVIEW PAPER Therapeutic Effect of Agmatine on Neurological Disease: Focus on Ion Channels and Receptors Sumit Barua1 · Jong Youl Kim1 · Jae Young Kim1 · Jae Hwan Kim4 · Jong Eun Lee1,2,3 Received: 15 October 2018 / Revised: 19 December 2018 / Accepted: 24 December 2018 / Published online: 4 January 2019 © Springer Science+Business Media, LLC, part of Springer Nature 2019 Abstract The central nervous system (CNS) is the most injury-prone part of the mammalian body. Any acute or chronic, central or peripheral neurological disorder is related to abnormal biochemical and electrical signals in the brain cells. As a result, ion channels and receptors that are abundant in the nervous system and control the electrical and biochemical environment of the CNS play a vital role in neurological disease. The N-methyl-D-aspartate receptor, 2-amino-3-(5-methyl-3-oxo-1,2-oxazol-4-yl) propanoic acid receptor, kainate receptor, acetylcholine receptor, serotonin receptor, α2-adrenoreceptor, and acid-sensing ion channels are among the major channels and receptors known to be key components of pathophysiological events in the CNS. The primary amine agmatine, a neuromodulator synthesized in the brain by decarboxylation of L-arginine, can regu- late ion channel cascades and receptors that are related to the major CNS disorders. In our previous studies, we established that agmatine was related to the regulation of cell differentiation, nitric oxide synthesis, and murine brain endothelial cell migration, relief of chronic pain, cerebral edema, and apoptotic cell death in experimental CNS disorders.
    [Show full text]
  • Agmatine and Agmatine Analogs in the Treatment of Epilepsy, Seizure, and Electroconvulsive Disorders Peter A
    University of Kentucky UKnowledge Pharmaceutical Sciences Faculty Patents Pharmaceutical Sciences 10-19-2010 Agmatine and Agmatine Analogs in the Treatment of Epilepsy, Seizure, and Electroconvulsive Disorders Peter A. Crooks University of Kentucky, [email protected] Aimee K. Bence David R. Worthen Right click to open a feedback form in a new tab to let us know how this document benefits oy u. Follow this and additional works at: https://uknowledge.uky.edu/ps_patents Part of the Pharmacy and Pharmaceutical Sciences Commons Recommended Citation Crooks, Peter A.; Bence, Aimee K.; and Worthen, David R., "Agmatine and Agmatine Analogs in the Treatment of Epilepsy, Seizure, and Electroconvulsive Disorders" (2010). Pharmaceutical Sciences Faculty Patents. 47. https://uknowledge.uky.edu/ps_patents/47 This Patent is brought to you for free and open access by the Pharmaceutical Sciences at UKnowledge. It has been accepted for inclusion in Pharmaceutical Sciences Faculty Patents by an authorized administrator of UKnowledge. For more information, please contact [email protected]. US007816407B2 (12) United States Patent (10) Patent N0.: US 7,816,407 B2 Crooks et al. (45) Date of Patent: Oct. 19, 2010 (54) AGMATINE AND AGMATINE ANALOGS IN The Merck Index, Merck Research Laboratories Division of Merck & THE TREATMENT OF EPILEPSY, SEIZURE, Co., Inc. 1996, p. 35. AND ELECTROCONVULSIVE DISORDERS James O. McNamara, “Drugs Effective in Therapy of the Epilepsies”, Goodman & Gilman’s The Pharmacological Basis of Therapeutics, (75) Inventors: Peter A. Crooks, Lexington, KY (US); Ninth Edition, Chapter 20, pp. 461-486, 1996. Aimee K. Bence, Lexington, KY (US); I. Tayfun Uzbay et al., “Effects of agmatine on ethanol Withdrawal David R.
    [Show full text]
  • Redalyc.Neurobiological Alterations in Alcohol Addiction: a Review
    Adicciones ISSN: 0214-4840 [email protected] Sociedad Científica Española de Estudios sobre el Alcohol, el Alcoholismo y las otras Toxicomanías España Erdozain, Amaia M.; Callado, Luis F. Neurobiological alterations in alcohol addiction: a review Adicciones, vol. 26, núm. 4, octubre-diciembre, 2014, pp. 360-370 Sociedad Científica Española de Estudios sobre el Alcohol, el Alcoholismo y las otras Toxicomanías Palma de Mallorca, España Available in: http://www.redalyc.org/articulo.oa?id=289132934009 How to cite Complete issue Scientific Information System More information about this article Network of Scientific Journals from Latin America, the Caribbean, Spain and Portugal Journal's homepage in redalyc.org Non-profit academic project, developed under the open access initiative revisión adicciones vol. 26, nº 3 · 2014 Neurobiological alterations in alcohol addiction: a review Alteraciones neurobiológicas en el alcoholismo: revisión Amaia M. Erdozain*,*** and Luis F. Callado*,** *Department of Pharmacology, University of the Basque Country UPV/EHU, Leioa, Bizkaia, Spain and Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain. **Biocruces Health Research Institute, Bizkaia, Spain. ***Neuroscience Paris Seine, Université Pierre et Marie Curie, Paris, France Resumen Abstract Todavía se desconoce el mecanismo exacto mediante el cual el etanol The exact mechanism by which ethanol exerts its effects on the brain produce sus efectos en el cerebro. Sin embargo, hoy en día se sabe is still unknown. However, nowadays it is well known that ethanol que el etanol interactúa con proteínas específicas de la membrana interacts with specific neuronal membrane proteins involved in neuronal, implicadas en la transmisión de señales, produciendo así signal transmission, resulting in changes in neural activity.
    [Show full text]
  • The Efficacy and Safety of Six-Weeks of Pre-Workout Supplementation in Resistance Trained Rats
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by College of William & Mary: W&M Publish W&M ScholarWorks Undergraduate Honors Theses Theses, Dissertations, & Master Projects 4-2017 The Efficacy and Safety of Six-Weeks of Pre-Workout Supplementation in Resistance Trained Rats Justin P. Canakis College of William and Mary Follow this and additional works at: https://scholarworks.wm.edu/honorstheses Part of the Animal Sciences Commons, Exercise Science Commons, Laboratory and Basic Science Research Commons, and the Other Nutrition Commons Recommended Citation Canakis, Justin P., "The Efficacy and Safety of Six-Weeks of Pre-Workout Supplementation in Resistance Trained Rats" (2017). Undergraduate Honors Theses. Paper 1128. https://scholarworks.wm.edu/honorstheses/1128 This Honors Thesis is brought to you for free and open access by the Theses, Dissertations, & Master Projects at W&M ScholarWorks. It has been accepted for inclusion in Undergraduate Honors Theses by an authorized administrator of W&M ScholarWorks. For more information, please contact [email protected]. 1 2 Title Page……………………………………………………………………………………...…..1 Abstract…………………………………………………………………………………………....5 Acknowledgement……………………………………………………………………….………..6 Background.………………………………………………………………………..……………...7 DSEHA and its Effect on the VMS Industry………………...……………………………7 History of Adverse Side Effects from Pre-Workout Supplements ………….……………8 Ingredient Analysis ………………………………………..……………….……………..……....9 2.5g Beta-Alanine…………………………..……………………………………………..9
    [Show full text]